April 20, 2018 article Open access Understanding the tumor immune microenvironment (TIME) for effective therapy Nature Medicine DOI: 10.1038/s41591-018-0014-x Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 24 stored of 6,380 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Establishment of a 3D Multicellular HCC Tumor Spheroid Model to Unravel Nrf2’s Influence on the Tumor Immune Microenvironment 2026 Bioengineering article Immunology and Microbiology Immune cells in cancer Open access 0 citations Single-cell spatial transcriptomics unravels cell states and ecosystems associated with clinical response to immunotherapy 2025 Journal for ImmunoTherapy of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access 23 citations Intratumoral gene delivery of 4-1BBL boosts IL-12-triggered anti-glioblastoma immunity 2025 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Glioma Diagnosis and Treatment Open access 0 citations Diversity of the immune microenvironment and response to checkpoint inhibitor immunotherapy in mucosal melanoma 2024 JCI Insight article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 1 patent 25 citations Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas 2024 Nature Communications article Medicine Lymphoma Diagnosis and Treatment Open access 5 citations Multimodal analysis unveils tumor microenvironment heterogeneity linked to immune activity and evasion 2024 iScience article Medicine Cancer Immunotherapy and Biomarkers Open access 16 citations Superparamagnetic Iron Oxide Nanoparticles Reprogram the Tumor Microenvironment and Reduce Lung Cancer Regrowth after Crizotinib Treatment 2024 ACS Nano article Immunology and Microbiology Immune cells in cancer Open access 48 citations Nanomedicine Tumor Targeting 2024 Advanced Materials article Materials Science Nanoparticle-Based Drug Delivery Open access 289 citations Multimodal analysis unveils tumor microenvironment heterogeneity linked to immune activity and evasion 2023 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Cancer Immunotherapy and Biomarkers Open access 0 citations Mechanisms driving the immunoregulatory function of cancer cells 2023 Nature reviews. Cancer review Medicine Cancer Immunotherapy and Biomarkers 272 citations When Cancer Cells Become the Enablers of an Antitumor Immune Response 2022 Cancer Discovery article Medicine Cancer Immunotherapy and Biomarkers Open access 22 citations Intravital microscopy for real-time monitoring of drug delivery and nanobiological processes 2022 Advanced Drug Delivery Reviews review Biochemistry, Genetics and Molecular Biology Advanced Fluorescence Microscopy Techniques Open access 31 citations Cancer-associated fibroblasts: Origin, function, imaging, and therapeutic targeting 2022 Advanced Drug Delivery Reviews review Medicine Cancer Cells and Metastasis Open access 195 citations Tumor-associated macrophages promote intratumoral conversion of conventional CD4 + T cells into regulatory T cells via PD-1 signalling 2022 OncoImmunology article Immunology and Microbiology Immune cells in cancer Open access 42 citations Immune Checkpoint Therapy: Tumor Draining Lymph Nodes in the Spotlights 2021 International Journal of Molecular Sciences article Medicine Cancer Immunotherapy and Biomarkers Open access 38 citations PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer. 2021 Journal of Nuclear Medicine article Medicine Cancer Immunotherapy and Biomarkers Open access 90 citations Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models 2021 Advanced Drug Delivery Reviews review Medicine Pancreatic and Hepatic Oncology Research Open access cited by 1 patent 111 citations A paradigm shift in cancer nanomedicine: from traditional tumor targeting to leveraging the immune system 2021 Drug Discovery Today article Materials Science Nanoparticle-Based Drug Delivery Open access 26 citations B-cell clusters at the invasive margin associate with longer survival in early-stage oral-tongue cancer patients 2021 OncoImmunology article Medicine Head and Neck Cancer Studies Open access 29 citations The Multifaceted Role of Regulatory T Cells in Breast Cancer 2020 Annual Review of Cancer Biology review Immunology and Microbiology T-cell and B-cell Immunology Open access 58 citations 1–20 of 24 Page 1 / 2 Next → References 0